80 related articles for article (PubMed ID: 9736045)
1. Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas.
Dobashi Y; Shoji M; Jiang SX; Kobayashi M; Kawakubo Y; Kameya T
Am J Pathol; 1998 Sep; 153(3):963-72. PubMed ID: 9736045
[TBL] [Abstract][Full Text] [Related]
2. Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer.
Yamaji H; Iizasa T; Koh E; Suzuki M; Otsuji M; Chang H; Motohashi S; Yokoi S; Hiroshima K; Tagawa M; Nakayama T; Fujisawa T
Cancer Immunol Immunother; 2004 Sep; 53(9):786-92. PubMed ID: 15185009
[TBL] [Abstract][Full Text] [Related]
3. Induction of cell apoptosis in non-small cell lung cancer cells by cyclin A1 small interfering RNA.
Cho NH; Choi YP; Moon DS; Kim H; Kang S; Ding O; Rha SY; Yang YJ; Cho SH
Cancer Sci; 2006 Oct; 97(10):1082-92. PubMed ID: 16984381
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of CYP2A13 in various types of human lung cancers.
Fukami T; Nakajima M; Matsumoto I; Zen Y; Oda M; Yokoi T
Cancer Sci; 2010 Apr; 101(4):1024-8. PubMed ID: 20180810
[TBL] [Abstract][Full Text] [Related]
5. p21 as a Predictor and Prognostic Indicator of Clinical Outcome in Rectal Cancer Patients.
Ooi LC; Ho V; Zhu JZ; Lim S; Chung L; Abubakar A; Rutland T; Chua W; Ng W; Lee M; Morgan M; MacKenzie S; Lee CS
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255799
[TBL] [Abstract][Full Text] [Related]
6. Identification and Verification of Biomarker in Clear Cell Renal Cell Carcinoma via Bioinformatics and Neural Network Model.
Liu B; Xiao Y; Li H; Zhang AL; Meng LB; Feng L; Zhao ZH; Ni XC; Fan B; Zhang XY; Zhao SB; Liu YB
Biomed Res Int; 2020; 2020():6954793. PubMed ID: 32626756
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Stimulation of Nurr1 Promotes Cell Cycle Progression in Adult Hippocampal Neural Stem Cells.
Moon H; Jeon SG; Kim JI; Kim HS; Lee S; Kim D; Park S; Moon M; Chung H
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861329
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
[TBL] [Abstract][Full Text] [Related]
9. MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cells.
Wang Z; Zhang M; Shan R; Wang YJ; Chen J; Huang J; Sun LQ; Zhou WB
Oncol Rep; 2019 Nov; 42(5):1915-1923. PubMed ID: 31485632
[TBL] [Abstract][Full Text] [Related]
10. Pro-Proliferative Function of Mitochondrial Sirtuin Deacetylase SIRT3 in Human Melanoma.
George J; Nihal M; Singh CK; Zhong W; Liu X; Ahmad N
J Invest Dermatol; 2016 Apr; 136(4):809-818. PubMed ID: 26743598
[TBL] [Abstract][Full Text] [Related]
11. Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways.
Horiuchi D; Huskey NE; Kusdra L; Wohlbold L; Merrick KA; Zhang C; Creasman KJ; Shokat KM; Fisher RP; Goga A
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):E1019-27. PubMed ID: 22474407
[TBL] [Abstract][Full Text] [Related]
12. Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas.
Ding XJ; Liu MX; Ao L; Liang YR; Cao Y
Virchows Arch; 2011 May; 458(5):561-9. PubMed ID: 21279520
[TBL] [Abstract][Full Text] [Related]
13. Role of cell cycle regulators in lung carcinogenesis.
Eymin B; Gazzeri S
Cell Adh Migr; 2010; 4(1):114-23. PubMed ID: 20139697
[TBL] [Abstract][Full Text] [Related]
14. Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas.
Aamodt R; Jonsdottir K; Andersen SN; Bondi J; Bukholm G; Bukholm IR
Gastroenterol Res Pract; 2009; 2009():285830. PubMed ID: 20029639
[TBL] [Abstract][Full Text] [Related]
15. Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin.
Suzuki A; Horiuchi A; Ashida T; Miyamoto T; Kashima H; Nikaido T; Konishi I; Shiozawa T
J Cell Mol Med; 2010 Sep; 14(9):2305-17. PubMed ID: 19583808
[TBL] [Abstract][Full Text] [Related]
16. Cdk1, Plks, Auroras, and Neks: the mitotic bodyguards.
Salaun P; Rannou Y; Prigent C
Adv Exp Med Biol; 2008; 617():41-56. PubMed ID: 18497029
[No Abstract] [Full Text] [Related]
17. Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE).
Deutsch EW; Ball CA; Berman JJ; Bova GS; Brazma A; Bumgarner RE; Campbell D; Causton HC; Christiansen JH; Daian F; Dauga D; Davidson DR; Gimenez G; Goo YA; Grimmond S; Henrich T; Herrmann BG; Johnson MH; Korb M; Mills JC; Oudes AJ; Parkinson HE; Pascal LE; Pollet N; Quackenbush J; Ramialison M; Ringwald M; Salgado D; Sansone SA; Sherlock G; Stoeckert CJ; Swedlow J; Taylor RC; Walashek L; Warford A; Wilkinson DG; Zhou Y; Zon LI; Liu AY; True LD
Nat Biotechnol; 2008 Mar; 26(3):305-12. PubMed ID: 18327244
[TBL] [Abstract][Full Text] [Related]
18. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.
Vermeulen K; Van Bockstaele DR; Berneman ZN
Cell Prolif; 2003 Jun; 36(3):131-49. PubMed ID: 12814430
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance.
Kato N; Watanabe J; Jobo T; Nishimura Y; Fujisawa T; Kamata Y; Kuramoto H
J Cancer Res Clin Oncol; 2003 Apr; 129(4):222-6. PubMed ID: 12684894
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CDK2 is a prognostic indicator of oral cancer progression.
Mihara M; Shintani S; Nakahara Y; Kiyota A; Ueyama Y; Matsumura T; Wong DT
Jpn J Cancer Res; 2001 Mar; 92(3):352-60. PubMed ID: 11267947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
